• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入麻醉:从乙醚到氙气。

Inhalation anaesthesia: from diethyl ether to xenon.

作者信息

Bovill J G

机构信息

Department of Anaesthesiology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Handb Exp Pharmacol. 2008(182):121-42. doi: 10.1007/978-3-540-74806-9_6.

DOI:10.1007/978-3-540-74806-9_6
PMID:18175089
Abstract

Modern anaesthesia is said to have began with the successful demonstration of ether anaesthesia by William Morton in October 1846, even though anaesthesia with nitrous oxide had been used in dentistry 2 years before. Anaesthesia with ether, nitrous oxide and chloroform (introduced in 1847) rapidly became commonplace for surgery. Of these, only nitrous oxide remains in use today. All modern volatile anaesthetics, with the exception of halothane (a fluorinated alkane), are halogenated methyl ethyl ethers. Methyl ethyl ethers are more potent, stable and better anaesthetics than diethyl ethers. They all cause myocardial depression, most markedly halothane, while isoflurane and sevoflurane cause minimal cardiovascular depression. The halogenated ethers also depress the normal respiratory response to carbon dioxide and to hypoxia. Other adverse effects include hepatic and renal damage. Hepatitis occurs most frequently with halothane, although rare cases have been reported with the other agents. Liver damage is not caused by the anaesthetics themselves, but by reactive metabolites. Type I hepatitis occurs fairly commonly and takes the form of a minor disturbance of liver enzymes, which usually resolves without treatment. Type II, thought to be immune-mediated, is rare, unpredictable and results in a severe fulminant hepatitis with a high mortality. Renal damage is rare, and was most often associated with methoxyflurane because of excessive plasma fluoride concentrations resulting from its metabolism. Methoxyflurane was withdrawn from the market because of the high incidence of nephrotoxicity. Among the contemporary anaesthetics, the highest fluoride concentrations have been reported with sevoflurane, but there are no reports of renal dysfunction associated with its use. Recently there has been a renewed interest in xenon, one of the noble gases. Xenon has many of the properties of an ideal anaesthetic. The major factor limiting its more widespread is the high cost, about 2,000 times the cost of nitrous oxide.

摘要

现代麻醉学据说始于1846年10月威廉·莫顿成功演示乙醚麻醉,尽管早在两年前一氧化二氮就已用于牙科麻醉。乙醚、一氧化二氮和氯仿(于1847年引入)麻醉迅速成为外科手术的常用方法。其中,只有一氧化二氮至今仍在使用。除氟烷(一种氟化烷烃)外,所有现代挥发性麻醉剂都是卤代甲基乙基醚。甲基乙基醚比二乙醚麻醉作用更强、更稳定,是更好的麻醉剂。它们都会引起心肌抑制,氟烷最为明显,而异氟烷和七氟烷引起的心血管抑制最小。卤代醚还会抑制对二氧化碳和低氧的正常呼吸反应。其他不良反应包括肝和肾损伤。氟烷最常引起肝炎,不过也有其他麻醉剂引起罕见病例的报道。肝损伤不是由麻醉剂本身引起的,而是由活性代谢产物导致的。I型肝炎相当常见,表现为肝酶的轻微紊乱,通常无需治疗即可恢复。II型肝炎被认为是免疫介导的,很罕见,不可预测,会导致严重的暴发性肝炎,死亡率很高。肾损伤很罕见,最常与甲氧氟烷有关,因为其代谢会导致血浆氟浓度过高。由于肾毒性发生率高,甲氧氟烷已退出市场。在当代麻醉剂中,七氟烷的氟浓度最高,但尚无与其使用相关的肾功能障碍报告。最近,人们对惰性气体之一的氙重新产生了兴趣。氙具有许多理想麻醉剂的特性。限制其更广泛应用的主要因素是成本高昂,约为一氧化二氮成本的2000倍。

相似文献

1
Inhalation anaesthesia: from diethyl ether to xenon.吸入麻醉:从乙醚到氙气。
Handb Exp Pharmacol. 2008(182):121-42. doi: 10.1007/978-3-540-74806-9_6.
2
[Xenon anaesthesia--clinical characteristics, benefits and disadvantages and fields of application].[氙气麻醉——临床特征、优缺点及应用领域]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2012 Jun;47(6):374-80. doi: 10.1055/s-0032-1316478. Epub 2012 Jun 28.
3
The haemodynamic and catecholamine response to xenon/remifentanil anaesthesia in Beagle dogs.比格犬对氙气/瑞芬太尼麻醉的血流动力学和儿茶酚胺反应。
Lab Anim. 2008 Jul;42(3):338-49. doi: 10.1258/la.2007.007048.
4
Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.七氟烷。其药效学和药代动力学特性及其在全身麻醉中的临床应用综述。
Drugs. 1996 Apr;51(4):658-700. doi: 10.2165/00003495-199651040-00009.
5
Clinical pharmacokinetics of the inhalational anaesthetics.吸入性麻醉药的临床药代动力学。
Clin Pharmacokinet. 1987 Mar;12(3):145-67. doi: 10.2165/00003088-198712030-00001.
6
[Intravenous anesthesia with inhalation anesthetics].[静脉麻醉与吸入麻醉剂]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1995 Oct;30(6):383-6. doi: 10.1055/s-2007-996514.
7
Xenon as an anesthetic agent.氙作为一种麻醉剂。
AANA J. 2010 Oct;78(5):387-92.
8
Spontaneous hyperactivity in mutant mice lacking the NMDA receptor GluRepsilon1 subunit is aggravated during exposure to 0.1 MAC sevoflurane and is preserved after emergence from sevoflurane anaesthesia.缺乏NMDA受体GluRepsilon1亚基的突变小鼠的自发活动亢进在暴露于0.1MAC七氟醚期间会加重,并且在七氟醚麻醉苏醒后仍会持续。
Eur J Anaesthesiol. 2008 Dec;25(12):953-60. doi: 10.1017/S0265021508004626.
9
Nitrous or nitric? Same difference. Molecular formulas in the 1840s.一氧化二氮还是一氧化氮?没什么区别。19世纪40年代的分子式。
J Clin Anesth. 2007 Mar;19(2):159-61. doi: 10.1016/j.jclinane.2006.08.009.
10
Halogenated inhalational anaesthetics.卤化吸入麻醉剂。
Best Pract Res Clin Anaesthesiol. 2003 Mar;17(1):29-46. doi: 10.1053/bean.2002.0265.

引用本文的文献

1
Nephrotoxicity and Modern Volatile Anesthetics: A Narrative Review.肾毒性与现代挥发性麻醉剂:一篇叙述性综述
Toxics. 2025 Jun 19;13(6):514. doi: 10.3390/toxics13060514.
2
General Anesthetics: Aspects of Chirality, Pharmacodynamics, and Pharmacokinetics.全身麻醉药:手性、药效学和药代动力学方面
Pharmaceuticals (Basel). 2025 Feb 13;18(2):250. doi: 10.3390/ph18020250.
3
Inhaled Anesthetics: Beyond the Operating Room.吸入麻醉剂:手术室之外
J Clin Med. 2024 Dec 10;13(24):7513. doi: 10.3390/jcm13247513.
4
The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review.γ-氨基丁酸受体在麻醉和镇静中的作用:最新综述
CNS Drugs. 2025 Jan;39(1):39-54. doi: 10.1007/s40263-024-01128-6. Epub 2024 Oct 27.
5
The Role of GABA Receptor Agonists in Anesthesia and Sedation.GABA 受体激动剂在麻醉和镇静中的作用。
CNS Drugs. 2017 Oct;31(10):845-856. doi: 10.1007/s40263-017-0463-7.
6
An observational study on patient admission in the anaesthesia gas monitor and minimum alveolar concentration monitoring: A deficiency with huge impact.麻醉气体监测与最低肺泡浓度监测中患者入院情况的观察性研究:一个影响巨大的缺陷。
Indian J Anaesth. 2017 Jul;61(7):570-574. doi: 10.4103/ija.IJA_11_17.
7
Perioperative Evaluation of Patients with Pulmonary Conditions Undergoing Non-Cardiothoracic Surgery.接受非心胸外科手术的肺部疾病患者的围手术期评估
Health Serv Insights. 2016 Nov 9;9(Suppl 1):9-23. doi: 10.4137/HSI.S40541. eCollection 2016.
8
Comparison of speed of inhalational induction in children with and without congenital heart disease.先天性心脏病患儿与非先天性心脏病患儿吸入诱导速度的比较。
Ann Card Anaesth. 2016 Jul-Sep;19(3):468-74. doi: 10.4103/0971-9784.185531.
9
XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.氙气在医学领域的应用:着重于缺氧和麻醉状态下的神经保护作用。
Med Gas Res. 2013 Feb 1;3(1):4. doi: 10.1186/2045-9912-3-4.
10
Xenon: a solution for anesthesia in liver disease?氙气:肝病麻醉的一种解决方案?
Hepat Mon. 2012 Nov;12(11):e8437. doi: 10.5812/hepatmon.8437. Epub 2012 Nov 20.